Bausch Health Cos Share Holder Equity 2010-2024 | BHC

Bausch Health Cos share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Bausch Health Cos Annual Share Holder Equity
(Millions of US $)
2023 $-82
2022 $260
2021 $-34
2020 $605
2019 $1,136
2018 $2,815
2017 $5,944
2016 $3,258
2015 $6,029
2014 $5,402
2013 $5,233
2012 $3,717
2011 $3,930
2010 $4,911
2009 $1,354
Bausch Health Cos Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $-242
2024-06-30 $-227
2024-03-31 $-174
2023-12-31 $-82
2023-09-30 $-235
2023-06-30 $271
2023-03-31 $145
2022-12-31 $260
2022-09-30 $433
2022-06-30 $253
2022-03-31 $-141
2021-12-31 $-34
2021-09-30 $-135
2021-06-30 $-611
2021-03-31 $-124
2020-12-31 $605
2020-09-30 $655
2020-06-30 $546
2020-03-31 $790
2019-12-31 $1,136
2019-09-30 $2,560
2019-06-30 $2,688
2019-03-31 $2,779
2018-12-31 $2,815
2018-09-30 $3,237
2018-06-30 $3,558
2018-03-31 $4,523
2017-12-31 $5,944
2017-09-30 $5,422
2017-06-30 $4,029
2017-03-31 $3,994
2016-12-31 $3,258
2016-09-30 $4,274
2016-06-30 $5,403
2016-03-31 $5,776
2015-12-31 $6,029
2015-09-30 $6,465
2015-06-30 $6,558
2015-03-31 $6,575
2014-12-31 $5,402
2014-09-30 $5,234
2014-06-30 $5,367
2014-03-31 $5,204
2013-12-31 $5,233
2013-09-30 $5,061
2013-06-30 $5,703
2013-03-31 $3,587
2012-12-31 $3,717
2012-09-30 $3,785
2012-06-30 $3,695
2012-03-31 $4,076
2011-12-31 $3,930
2011-09-30 $4,014
2011-06-30 $4,665
2011-03-31 $4,709
2010-12-31 $4,911
2010-09-30 $5,350
2010-06-30 $1,361
2010-03-31 $1,344
2009-12-31 $1,354
2009-09-30 $1,291
2009-06-30 $1,254
2009-03-31 $1,177
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.672B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $24.142B 7.92
Dr Reddy's Laboratories (RDY) India $12.621B 24.15
BridgeBio Pharma (BBIO) United States $4.953B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.975B 26.90
Amphastar Pharmaceuticals (AMPH) United States $1.894B 11.38
Taysha Gene Therapies (TSHA) United States $0.379B 26.43
Personalis (PSNL) United States $0.372B 0.00
Assembly Biosciences (ASMB) United States $0.100B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.008B 0.00
Teligent (TLGT) United States $0.000B 0.00